A Randomised Trial Investigating the Postprandial Glucose Metabolism After Treatment With Faster-acting Insulin Aspart in Subjects With Type 1 Diabetes
Phase of Trial: Phase I
Latest Information Update: 08 Dec 2017
At a glance
- Drugs Insulin aspart (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 08 Dec 2017 Results presented at the 2017 Congress of the International Diabetes Federation.
- 29 Apr 2016 Status changed from active, no longer recruiting to completed.
- 04 Apr 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.